HemaPrime™ Cryopreserved Leukopaks are intended to meet all your cell therapy project needs from the research and development (R&D) phase, where controlled cell numbers and guaranteed low granulocyte counts are beneficial, to the process development phase where inherent differences between donors are important to consider. A consistent manufacturing process between HemaPrime™ and GMPrime™ Cryopreserved Leukopaks (GMP-compliant leukopaks) enables a seamless transition from RUO to GMP-compliant cellular starting materials.